Search Results
Results found for "Adam W Smith"
- 📰 GPCR Weekly News, March 25 to March 31, 2024
This week's highlight includes congrats to: Junyi Liang, Niña Caculitan, and Adam W Smith for their research
- Dr. Nicola J. Smith - Dr. GPCR Podcast
Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney.
- Why Mastering Pharmacokinetics Fundamentals Still Defines Discovery Success Today
Although major advances in predictive tools have reduced PK-driven attrition, misconceptions about ADME Too often, fundamentals are undervalued: in vitro assays are treated as routine checkboxes, and ADME In This Session, You’ll Gain Clarity on how ADME governs translational success A deeper understanding The Independence of Drug Attributes Primary activity, ADME, and safety form three independent axes of ADME as the Engine of Translation True PK mastery reveals its value at the point of translation.
- Dr. GPCR Updates
w=cw8ae7XNuBdiMbjg4TeUw3rdv2qYhR4rv-bqGLmA948.eyJ1IjoiaHR0cHM6Ly9kb2kub3JnLzEwLjExMTEvYnBoLjcwMDcyIiwiciI6ImUyZGZlOTFjLTM5YzgtNDA5Yi04NTUyLWI5NjUwNGRlNzc4MyIsIm0iOiJtYWlsX2xwIiwiYyI6IjAwMDAwMDAwLTAwMDAtMDAwMC0wMDAwLTAwMDAwMDAwMDAwMCJ9
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
W.; Wu, Y.; Zhao, S.; Shui, W.; Li, S.; Korde, A.; Laprairie, R. B.; Stahl, E. L.; Ho, J. W.; Iyer, M. R.; Cinar, R.; Coffey, N. Chem. 2019 , 62 (1), 276–287. https://doi.org/10.1021/acs.jmedchem.8b00368 . (9) Adams, A. Martín-Fontecha, M.; Angelina, A.; Rückert, B.; Rueda-Zubiaurre, A.; Martín-Cruz, L.; Van De Veen, W. J.; Guba, W.; Alker, A.; Rufer, A. C.; Kusznir, E. A.; Huber, S.; Raposo, C.; Zirwes, E.
- Conjugation Strategies for Probe Development
W.; Santi, D. V. Long-Term Stabilization of Maleimide–Thiol Conjugates. W. Cu-Catalyzed Azide−Alkyne Cycloaddition. Chem.
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Shen S, Zhao C, Wu C, Sun S, Li Z, Yan W, et al. Crilly SE, Ko W, Weinberg ZY,Puthenveedu MA. Truong ME, Bilekova S, Choksi SP, Li W, Bugaj LJ, Xu K, et al. Franzen MM, Alder ML, Dreyer F, Köpp W, Buchholz MB. Wilner W. Participatory experience: the participant observer paradox.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
W.; Högl, B.; Bainbridge, J.; Buchfuhrer, M.; Hadjigeorgiou, G.; Inoue, Y.; Manconi, M.; Oertel, W.; Ondo, W.; Winkelmann, J.; Allen, R. . https://doi.org/10.1016/j.tips.2017.10.004 . (9) Marheineke, K.; Grünewald, S.; Christie, W. Dordrecht, 2014; pp 55–74. https://doi.org/10.1007/978-94-007-7423-0_4 . (12) Yung-Chi, C.; Prusoff, W.
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
.; Li, W.; Florin, N. C.; Scheiff, A. B.; Müller, C. , 2009; Vol. 193, pp 1–24. https://doi.org/10.1007/978-3-540-89615-9_1 . (8) Yung-Chi, C.; Prusoff, W.
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Terry W. Moore, was most definitely a success.
- VAMP2: a crucial player in the delivery of MOR to the synapse
vesicle-associated-membrane-protein-2-is-a-cargo-selective-v-snare-for-a-subset-of-gpcrs #GPCR #DrGPCR#Ecosystem Crilly, S.E., W. Wickner, W., and R. Schekman. 2008. Membrane fusion. Nat. Struct. Mol. Biol. 15:658–664.
- Nanobodies: New Dimensions in GPCR Signaling Research
H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013).
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Jang W, Senarath K, Feinberg G, Lu S, Lambert NA.
- Do You Believe AI Could Accelerate Drug Discovery?
Nature 630, 493–500 (2024). https://doi.org/10.1038/s41586-024-07487-w
- Fluorescence Polarization in GPCR Research
Adapted from: Zhang Y, Tang H, Chen W, Zhang J.
- Ode to GPCRs
Earl W. Earl W. Earl W. Sir James W. Sir James W.
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Stallaert, W., et al., Purinergic Receptor Transactivation by the β(2)-Adrenergic Receptor Increases
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Guo, W., et al., Crosstalk in G protein-coupled receptors: Changes at the transmembrane homodimer interface
- From DNA day to GPCR genomics
W., & Skiniotis, G. (2023).
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
G., Coyote-Maestas, W., & Aashish Manglik. (2024).
- Odorant receptors – a bit of smell for drug discovery
For example, OR4M1 was proposed to interfere with aberrant tau hyperphosphorylation (Zhao W. et. al 2013
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
. * In addition to the W-54011, the unmodified pharmacophore 1 was used as internal control for further
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
contributes to inflammatory joint pain Luke A Pattison , Rebecca H Rickman , Graham Ladds , Ewan St John Smith
- 📰 GPCR Weekly News, May 20 to 26, 2024
Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery Nicola J Smith
- Decoding β-Arrestins: from Structure to function
their imbalance is linked to pathological conditions, including cancer (Gros, R. et al. 2000, Sun, W.
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease
- Chemokine receptor-targeted drug discovery: progress and challenges
the engagement of the receptor with a certain effector, thus enriching a specific signaling pathway (Smith
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
previously established chemical space, limiting their ability to identify truly novel chemotypes”(Thomas, Smith















